Identification |
Name: | 9H-Imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylicacid, 11,12,13,13α-tetrahydro-7-methoxy-9-oxo-, ethyl ester, (13αS)-, |
CAS: | 130477-52-0 |
Molecular Formula: | C18H19N3O4 |
Molecular Weight: | 341.36 |
InChI: | InChI=1/C18H19N3O4/c1-3-25-18(23)15-16-14-5-4-8-20(14)17(22)12-9-11(24-2)6-7-13(12)21(16)10-19-15/h6-7,9-10,14H,3-5,8H2,1-2H3/t14-/m0/s1 |
Molecular Structure: |
|
Properties |
Flash Point: | 307.2°C |
Boiling Point: | 584.4°Cat760mmHg |
Density: | 1.42g/cm3 |
Refractive index: | 1.675 |
Water Solubility: | DMSO: 6 mg/mL |
Solubility: | DMSO: 6 mg/mL |
Appearance: | powder |
Biological Activity: | Potent, selective inverse agonist for the benzodiazepine site of GABA A receptors containing the α 5 subunit (K i = 0.45 nM). Displays 50-100-fold selectivity over GABA A receptors containing α 1, α 2, α 3 or α 6 subunits in combination with β 3 and γ 2. Enhances LTP in? a mouse hippocampal slice model and increases spatial learning, without displaying proconvulsant activity. |
Flash Point: | 307.2°C |
Safety Data |
|
|